advert
advert
Angel News

Back to Homepage

20th July 2021 - 0 comments

Ascension Ventures leads $400k investment in BEPPS Snacks

London-based startup, BEPPS Snacks, has raised £400,000 investment from early-stage venture capital investors, Ascension Ventures, 

20th July 2021 - 0 comments

Arete  backs multi-million investment in digital platform Vivify

Multi-family investment office, Arete, has made a significant investment as part of a multi-million-pound deal in North West based, Vivify. The scale-up provides a digital platform as well as a fully managed service where under-utilised school facilities can be listed for hire to maximise social and physical activities within communities and generate much-needed revenue for schools.

20th July 2021 - 0 comments

Risks for employers under life without lockdown

Alex Kennedy of Gannons looks at how to deal with the next phase of Covid regulations

Employers are thinking about how to manage their employees' return to work under the lifting of lockdown restrictions. We are hearing from employers unsure about their position: what changes they have to make and what requests for change from employees they can refuse.

Gannons has set out an overview of the key employment law requirements for employers post lock down designed to help employers rebuild their businesses.

20th July 2021 - 0 comments

Angels Assemble: The advantages of syndication in 2021

Remy Astie, CEO and founder of Vauban, makes the case for joining forces with other angels and highlights some of the benefits (for both investor and the companies they back).

In reaction to a COVID crisis that brought extremely low interest rates and an accelerated digital transformation, investors are increasingly exploring private investment opportunities in startups to enjoy better returns. 

20th July 2021 - 0 comments

How to embed change in your business

Karen Dunne-Squire from Elation Experts shares her five key steps to ensuring the change you want to embed in your business succeeds.

20th July 2021 - 0 comments

Future fund data is a curate’s egg. This is why.

 

Modwenna Rees-Mogg looks at the Future Fund statistics and asks just how helpful they really are?

 

19th July 2021 - 0 comments

SFC Capital calls for reform as UK first-time funding rounds down 36% from 2018 peak

The number of first-time funding rounds into UK seed-stage startups declined for a second consecutive year in 2020, to 36 per cent below the 2018 peak for such deals, according to new research commissioned by SFC Capital

19th July 2021 - 0 comments

Bower Collective raises £2.1m led by Oxford Capital

Bower Collective, the sustainable consumer goods business has raised £2.1 million in seed stage fundraising.  The round led by Oxford Capital and Doehler Ventures will accelerate the growth of the business through packaging innovation and new product development to increase market share. 

19th July 2021 - 0 comments

‘Revolutionary woundcare’ biotech firm raises £1.8m from MEIF

A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m.

Nottingham-based NuVision Biotherapies  has secured funding from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s EIS funds, Newable Ventures and private investors.

19th July 2021 - 0 comments

Dragonfly AI secures £250,000 from GLIF

Situated in the London borough of Westminster, technology company Dragonfly AI has secured a £250,000 loan to expand its operations whilst creating employment opportunities for the region.

16th July 2021 - 0 comments

Three quarters of IFAs believe Business Relief investments will increase

Three quarters (76%) of IFAs believe that their use of Business Relief propositions will increase over the next two years, 

16th July 2021 - 0 comments

Praetura Ventures leads £2.9m investment in Reacta Biotech

A business that is on course to transform the food allergy diagnostics market has secured £2.9m investment in a funding round led by Praetura Ventures with follow-on equity investment from the Development Bank of Wales.  Reacta Biotech (Reacta), which is based in Deeside, North Wales, produces clinical diagnostics kits for food allergy testing. The business improves the efficiency, accuracy and safety of food allergy testing by producing pharmaceutical grade Oral Food Challenges (OFCs), the gold standard test for diagnosing food allergies.

PREVIOUSItems 2244 of 7580NEXT

Back to Homepage